Form 4 for PCRX Pacira BioSciences, Inc.
Accepted 2024-08-02 00:00:00 ET · period of report 2024-08-01 · accession 0001396814-24-000100 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-08-02 | 2024-08-02 | PCRX | SLONIN JONATHAN | Chief Medical Off | S - Sale | $20.05 | -945 | 94.3K | -1.0% | -$18.9K | |
| 2024-08-02 | 2024-08-01 | PCRX | SLONIN JONATHAN | Chief Medical Off | F - Tax | $20.75 | -305 | 95.3K | -0.3% | -$6,329 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-08-02 | S | D | 945 | $20.05 | 94,306.75 | D | — | — | |
| 2 | Common | Common Stock | 2024-08-01 | F | D | 305 | $20.75 | 95,251.75 | D | — | — |